Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hemostatic abnormalities in HIV disease.

R B Stricker1

  • 1Division of Immunotherapy, Children's Hospital of San Francisco, California.

Hematology/Oncology Clinics of North America
|April 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antiphospholipid antibodies in patients with persistent Lyme disease symptoms.

Lupus·2011
Same author

Lyme disease diagnosis and treatment: lessons from the AIDS epidemic.

Minerva medica·2011
Same author

Safety of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease.

Minerva medica·2010
Same author

Attorney General forces Infectious Diseases Society of America to redo Lyme guidelines due to flawed development process.

Journal of medical ethics·2009
Same author

Complement split products c3a and c4a in chronic lyme disease.

Scandinavian journal of immunology·2009
Same author

"In silico experiments"--yes, but the great western cowboy "random chance" is still alive.

Fertility and sterility·2001

HIV infection causes mysterious bleeding problems like immune thrombocytopenia (ITP), TTP, and ACA. Understanding these platelet issues may improve treatments for autoimmune diseases and HIV/AIDS.

Area of Science:

  • Hematology
  • Immunology
  • Infectious Diseases

Background:

  • HIV infection is associated with significant hemostatic abnormalities, including immune thrombocytopenia (ITP), thrombotic thrombocytopenic purpura (TTP), and antiphospholipid antibodies (ACA).
  • The precise mechanisms underlying platelet destruction and the initiation of these hemostatic disorders in HIV-infected individuals remain poorly understood.
  • Managing these conditions in patients with Acquired Immunodeficiency Syndrome (AIDS) presents unique clinical challenges.

Purpose of the Study:

  • To explore the pathogenesis and treatment of HIV-related ITP, TTP, and ACA.
  • To investigate the role of HIV in triggering hemostatic abnormalities.
  • To establish HIV-related thrombocytopenia as a model for understanding other immune cytopenias and autoimmune diseases.

Related Experiment Videos

Main Methods:

  • The abstract does not specify the methods used.
  • Discussion focuses on the enigmatic nature of HIV-related hemostatic disorders.
  • Literature review and clinical case discussions are implied.

Main Results:

  • The mechanisms of platelet destruction in HIV patients are not well-defined.
  • The triggers for HIV-induced hemostatic abnormalities are unknown.
  • HIV-related ITP, TTP, and ACA are conceptualized as part of a spectrum of autoimmune processes in AIDS.

Conclusions:

  • Further research into HIV-related hemostatic abnormalities is crucial for developing effective treatments.
  • Understanding these autoimmune processes in AIDS can lead to improved therapeutic strategies for HIV disease.
  • HIV-related thrombocytopenia serves as a valuable model for advancing the treatment of various autoimmune diseases.